Global Engage is pleased to announce the Adoptive Cell Transfer Congress part of the Research & Technology Series. Exploring the exciting field of cell and gene therapy in immuno-oncology, this meeting is not one to be missed!
The modification of patient and donor t cells offers a potent weapon in the fight against cancer, and with the recent regulatory approval, several CAR-T Cell products in the US and Europe these therapies stand poised to enter the clinic.
This conference offers experts working in the pharmaceutical industry as well as academia the opportunity to explore the latest developments in CAR T cell therapies, and the up-and-coming field of T Cell Receptor therapies. Presentations will explore design and development strategies for the modification of patient and donor t cells, receptor engineering and target selection, and will review the advantages and challenges remaining in their use.
With 20 expert speakers scheduled to present, this meeting will allow you to keep up to date with the cutting edge of research and the opportunity to further research and business partnerships with those in your field
The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.